Comparison Chart of Illicit Heroin Addiction and Stabilized Methadone Maintenance

This chart was prepared by Herman Joseph and Joycelyn Sue
Woods and is reprinted from METHADONE TREATMENT WORKS: A COMPENDIUM FOR
METHADONE MAINTENANCE TREATMENT

Topic Illicit Heroin Addiction Stabilized Methadone Maintenance
Onset of action Immediate 30 minutes
Duration of action 4 – 6 hours 24 – 36 hours or half-life
Route of administration Injection, snorting, smoking ( several times a day ) Orally administered once per day
Effective dose Not applicable For many patients 60 mg/day is lowest effective dose; doses between
80 and 120 mgs/day are most effective for preventing HIV transmission
retention in treatment, reducing the use of other drugs and increasing
social productivity.
Overall safety potentially lethal Medically safe, no toxic effects found in patients maintained on
methadone for up to 18 years.
Overdose Can die from overdose of narcotics; potentially lethal, even for
tolerant individuals death can occur quite fast without proper medical
treatment with narcan.
A degree of protection from death by overdose is achieved when
receiving 100 mg/day or more; methadone is potentially lethal for
non-tolerant individuals, death can occur but more slowly than heroin
overdose however, overdose reaction can be reversed and person’s life
saved if narcotic antagonist such as narcan is prescribed for 24 – 36
hours
Narcotic effects of other opiates ( if tried ) Feels narcotic effects of opiates At 80 mgs/day or more narcotic effects of opiates are blocked
Withdrawal syndrome Can be severe, but can be controlled with methadone Less severe than heroin but more extended, can be controlled by
slow reduction in methadone dose
Mood alteration Constant swings None, if patient is not emotionally disturbed or using other drugs
Euphoric effects Approximately 2 hours duration after administration None after administration
Tolerance level Increasing dosage needed Stable level at some dose
Narcotic craving Recurring Relieved and blocked
HIV transmission Effective transmission Transmission of HIV by injection reduced or eliminated for patients
who remain in treatment
Immune and endocrine functioning in HIV- persons Impaired Normalizes during treatment
Immune and endocrine functioning in HIV+ persons Rapid progression to AIDS Preliminary studies indicate that the progression to AIDS is slower
Hypothalamus Pituitary Adrenal Axis Suppressed Normalizes during treatment
Sexual functioning / libido Impaired Normalizes during treatment
Female menses Impaired Normalizes during treatment
Pregnancy Serious problems difficult to treat Problems can be brought under control with medical, social and
prenatal care
Emotional affect Impaired Normal, if patient is not emotionally disturbed or using other
drugs
Pain and emotion Blunted Feels normal pain and experiences normal range of emotion if not
abusing other drugs
Intellectual functioning Impaired Normal if person is not emotionally disturbed or using other drugs
Physical reaction time Impaired Normalizes during treatment
Personal relationships Disrupted Restored with counseling
Social functioning Impaired Normalizes with counseling
Vocational rehabilitation and education High proportion of failure High proportion of success in vocational rehabilitation, education
and employability
Employment Difficult if not impossible to hold a job Can function in every level ant type of profession e.g.: bus
driver, lawyer, doctor, teacher, pilot
Mental illness Difficult to treat Treatable if integrated resources exists, however many psychiatric
services discriminate against methadone patients and will not accept
them
Poly-drug abuse High level ( alcohol, crack, cocaine, nicotine, etc. ) High level but potentially treatable
Criminal drug abuse Constant high level Reduced level or eliminated
Effect on community Destructive, high crime and death rates, transmission of disease A good methadone program contributes to public safety, reduces
mortality and improves quality of life for all
Criteria for addiction Fits criteria for addiction as listed in the “Diagnostic and
Statistical Manual of Mental Disorders”
Does not fit criteria for addiction, methadone maintenance is a
thoroughly researched and effective medical treatment
Life-style Heroin addiction is about acquired infection and death Methadone maintenance treatment is about good health and life.
Methadone chemotherapy normalizes a deranged physiology so patients can
stabilize their lives
This chart was prepared by Herman Joseph and Joycelyn
Sue Woods and is reprinted from METHADONE TREATMENT WORKS: A COMPENDIUM
FOR METHADONE MAINTENANCE TREATMENT
(Part 1) 1994: p 19-20. From the
Chemical Dependency Research Working Group Monograph Series, No. 2. New
York. New York State Office of Alcoholism and Substance Abuse Services (OASAS)
and Mental and Health Research Association of New York City, Inc. (MHRA).

For more information about the activities of the Chemical
Dependency Research Working Group (CDRWG) contact the Chair, Dr. Herman
Joseph at NYS OASAS, 55 West 125 Street, New York, NY 10025,(212)
961-8491, FAX (212) 961-8318

Similar Posts

  • About TEXNAMA

    Admin 03/17/2022

    Methadone Advocacy: The Time Has Come There are many approaches that a methadone advocacy organization can utilize to bring about change. TexNAMA’s primary objective (as part of NAMA) is the empowerment of patients. By confronting the negative stereotypes TexNAMA works to end the stigma and discrimination that has made recovery and reintegration back into society…

  • Risk Factors for HCV

    Admin 03/22/2023

    HCV Info Fact 24 August 2003 The risk factors for Hepatitis C Virus infection are: Intravenous drug use- Current or remote intravenous drug use accounts for 50% of new cases of HVC; 50% to 60% infected with HCV within 3 months of initiation of injection behavior Intranasal cocaine- Risk factor suggested by epidemiologic evidence Tattooing…

  • The First Methadone Advocacy Conference

    Admin 04/25/2022

      Time:  September 26, 1998  9:30 AM to 5 PM Place: Roosevelt Hospital Auditorium  1000 Tenth Avenue  between 58-59th Street  New York City Topics:  A conference for methadone patients and by methadone patients. This important conference gives a voice to the voiceless. Topics discussed will be stigma, prejudice, misunderstandings about methadone, new regulations, physician prescribing…

  • Month: May 2019

    Admin 08/08/2021

    Herman Joseph, PhD 1931 – 2019 May 28, 2019 May 6, 2019 Dr. Joseph was one of the important influences on addiction and criminal justice during the latter 20th and early 21st century.  For more than 50 years he has worked as a social research scientist in the interrelated fields of addiction, treatment, criminal justice,…

  • OBOT Publications

    Admin 04/20/2023

    Publications Office Based Opioid Treatment Federal Code U.S. Federal Code. Confidentiality of Alcohol and Drug Abuse Patient Records. U.S. Federal Code. Medical Privacy HIPPA, National Standards to Protect the Privacy of Personal Health Information. Public Law 106-310, 106th Congress Sec. 3502. Controlled Substances Act, October 17, 2000. Physician Waiver to Prescribe, Dispense Schedule III-V Narcotic Drugs in the…

  • Answer one

    Admin 12/31/2022

    FALSE! Current research shows that doses below 60 mg/day are “not effective and hence not appropriate” and that low dose policies for pregnant and non-pregnant patients are associated with increased drug use as well as reduced program retention. Medical withdrawal of opioid dependent women is not recommended in pregnancy because of increased risk to the…